Cas:1072959-67-1 SR-3677 manufacturer & supplier

Chemical Name:SR-3677

CAS.NO:1072959-67-1

Synonyms:rs0088;hms3244c10;1,4-Benzodioxin-2-carboxamide, N-[2-[2-(dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-;hms3244d09;N-{2-[2-(Dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl}-2,3-dihydro-1,4-benzodioxine-2-carboxamide;sr3677;hms3244c09;SR-3677

Molecular Formula:C₂₂H₂₄N₄O₄

Molecular Weight:408.450

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:646.9±55.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.632

PSA:92.20000

Exact Mass:408.179749

LogP:2.34

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like rs0088 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,SR-3677 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,hms3244c10 Use and application,hms3244d09 technical grade,usp/ep/jp grade.

Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. SR-3677 manufacturer As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters. SR-3677 supplier As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters. SR-3677 vendor However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them. SR-3677 factory As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters.